U.S. Pharmacist Weekly News Update
December 11, 2019

Survey Reveals Physicians’ Reasons For Deprescribing—
or Not

What situations are most likely to lead to cardiovascular drug deprescribing by physicians and how does that differ by specialty? Pharmacists, who deal with the fallout from polypharmacy every day, might find the answers to those questions very interesting. Here is information from a new survey.


Emergency Treatments for
Status Epilepticus Deemed Equal

Getting status epilepticus under control quickly is important to reduce the risk of cardiac and respiratory complications. That can be complicated, however, when patients don’t respond to benzodiazepine therapy. Find out how the three alternative medications most often used in emergency care compare in terms of safety and effectiveness.

Obesity Appears to Affect Response to Some Antiarrhythmic Medications
Pharmacists should be very interested in a new study suggesting that obesity can affect response to drugs used to treat atrial fibrillation. Find out how researchers determined that patients with obesity had significantly greater recurrence of atrial fibrillation compared with those without obesity who received sodium channel blocker antiarrhythmic drugs.

Stopping Asthma Drugs
During Pregnancy Could
Harm Mothers, Children

Worried about effects on the fetus, about 40% of pregnant women with asthma decrease or stop taking their medications. The problem, according to a new study, is that suffering severe asthma symptoms during pregnancy might be far worse than drug effects. Find out more details on outcomes for both the mothers and their children.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App